Carregant...

Autocrine motility factor and its receptor expression in musculoskeletal tumors

Management of aggressive malignant musculoskeletal tumors is clinically challenging and awaits the identification of regulator(s) that can be therapeutically used to improve patient outcome. Autocrine motility factor (AMF), a secreted cytokine, is known to alter the bone microenvironment by linking...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Bone Oncol
Autors principals: Nakajima, Kosei, Raz, Avraham
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7574284/
https://ncbi.nlm.nih.gov/pubmed/33101887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2020.100318
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!